Post-marketing surveillance of a femoral stem prosthesis for hip replacement
Official title: The Medacta SMS Femoral Stem Component. A Multi-National, Multi-Centre, Clinical Surveillance Study
Run by Medacta International SA · NCT02748408 · Data updated 2026-11-12
This study is tracking how well a specific hip replacement device works and its safety in people aged 18 to 75 who are having hip surgery for different joint problems.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 550 (estimated) |
| Sponsor | Medacta International SA Industry-sponsored |
| Locations | 4 sites (Vienna and 3 other locations) |
| Status | Recruiting |
| Started | July 2015 |
| Main results expected | July 2032 |
| Study ends | July 2032 |
| Registry record updated | October 13, 2026 |
| Trial ID | NCT02748408 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals aged 18 to 75 with severely painful hip joint conditions who are scheduled for a primary total hip replacement.
✕Probably not a fit
Patients with active infections, pregnancy, or certain medical conditions that may compromise their ability to participate or benefit from the study will not receive benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study monitors the performance and outcomes of the SMS femoral stem prosthesis in patients undergoing total hip replacement. It aims to gather data on the effectiveness and safety of the prosthesis in individuals suffering from various hip joint conditions, including arthrosis and avascular necrosis. Participants will be followed for a period of 10 years to assess their progress and any potential complications associated with the implant. The study includes patients aged 18 to 75 who are scheduled for primary hip replacement surgery.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the long-term effectiveness and safety of the SMS femoral stem prosthesis, potentially improving patient outcomes in hip replacement surgeries.
How similar studies have gone: Other studies on post-marketing surveillance of orthopedic implants have shown success in monitoring long-term outcomes, suggesting this approach is validated.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Individuals with a severely painful and/or disabling hip joint with osteoarthritis, traumatic arthritis or developmental dysplasia of the hip or avascular necrosis of the femoral head. * In order to take part in this study, all study participants must be between the ages of 18 and 75 years of age, at the time of surgery. * Scheduled for a primary total hip replacement. Exclusion Criteria: * Active infection * Pregnancy * Mental illness where the known condition is likely to compromise the patient's ability to consent, affect the patient's assessment of their progress or complete the 10 year cycle of follow-up appointments and reviews * Grossly distorted anatomy (surgeon's discretion) * Osteomalacia where uncemented implant fixation is contraindicated * Active rheumatoid arthritis. * Osteoporosis * Metabolic disorders which may impair bone formation where uncemented implant fixation is contraindicated * Muscular atrophy or neuromuscular disease * Allergy to implant material * Any patient who cannot or will not provide informed consent for participation in the study * Those whose prospects for a recovery to independent mobility would be compromised by known coexistent, medical problems
Where it's running
-
Herz-Jesu Krankenhaus
Vienna, Austria Recruiting -
Istituto Ortopedico Galezzi
Milan, Milan, Italy Recruiting -
Bürgerspital Solothurn
Solothurn, Switzerland Recruiting -
The Elective Orthopaedic Centre (EOC)
Epsom, Surrey, United Kingdom Recruiting
Study contacts
- Study coordinator: Mara Colombo, Eng
- Email: colombo@medacta.ch
- Phone: 0041 91 6966060
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
EMPHASYS cup placement with VELYS non-invasive hip navigation in total hip replacement
This research tests whether using the VELYS non-invasive hip navigation system helps surgeons place the EMPHASYS acetabular cup more accurately during total hip replacement for people with osteoarthritis or other hip conditions.
-
Changes in activity, sleep, and knee function after same-day discharge knee replacement
This study tests how physical activity, sleep, knee strength and motion, and patient-reported outcomes change before and after same-day discharge knee replacement in people with knee osteoarthritis.
-
Tornier Perform Reversed MonoPost Shoulder Implant: Patient Follow-Up in Real World Care
This study tests how well the Tornier Perform Reversed MonoPost shoulder implant works in adults with shoulder problems over two years by following patients after surgery at multiple centers.
-
Custom 3D-printed total ankle and talus replacement for severe bone loss
This project will try a custom 3D-printed ankle and talus implant to restore function in adults aged 35–75 with severe talar bone loss or compromised ankle bone.
-
Z1 Hip System post-market follow-up
This tests whether the Z1 Femoral Hip System is safe and helpful for adults having total or hemi hip replacement for osteoarthritis, femoral head/neck fractures, or avascular necrosis.
-
Evaluating wrist and carpal fusion surgeries for pain relief and stability
This study is testing different wrist surgeries to see if they can help people with chronic pain and instability feel better and regain function after other treatments haven't worked.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.